Role of rituximab in the treatment of splenic marginal zone lymphoma.

被引：0
|
作者：
Al Shehadat, S [1 ]
Bast, MA [1 ]
Sehi, G [1 ]
Bociek, GR [1 ]
Kessinger, A [1 ]
Armitage, JO [1 ]
机构：
[1] Univ Nebraska, Med Ctr, Dept Internal Med, Hematol Oncol Sect, Omaha, NE USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4694
引用
收藏
页码：253B / 254B
页数：2
相关论文
共 50 条
  • [1] SPLENECTOMY VERSUS RITUXIMAB IN THE TREATMENT OF SPLENIC MARGINAL ZONE LYMPHOMA
    Kalpadakis, C.
    Pangalis, G. A.
    Vassilakopoulos, T. P.
    Sachanas, S.
    Kyrtsonis, M. C.
    Dimopoulou, M.
    Korkolopoulou, P.
    Kontopidou, F. N.
    Yiakoumis, X.
    Siakantaris, M. P.
    Dimitriadou, E. M.
    Panayiotidis, P.
    Papadaki, H.
    Angelopoulou, M. K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 168 - 169
  • [2] Treatment of Splenic Marginal Zone Lymphoma: Splenectomy Versus Rituximab
    Bennett, Michael
    Schechter, Geraldine P.
    SEMINARS IN HEMATOLOGY, 2010, 47 (02) : 143 - 147
  • [3] Rituximab monotherapy in splenic marginal zone lymphoma
    Bennett, M.
    Dave, H. P.
    Dann, E. J.
    Yegena, S.
    Chubar, E.
    Schechter, G. P.
    ANNALS OF ONCOLOGY, 2008, 19 : 228 - 228
  • [4] Rituximab monotherapy for splenic marginal zone lymphoma
    Bennett, Michael
    Sharma, Kumud
    Yegena, Shaiy
    Gavish, Israel
    Dave, Harish P.
    Schechter, Geraldine P.
    HAEMATOLOGICA, 2005, 90 (06) : 856 - 858
  • [5] Treatment of Splenic Marginal Zone Lymphoma with Rituximab Monotherapy in 59 Patients
    Kalpadakis, Christina H.
    Pangalis, Gerassimos
    Vassilakopoulos, Theodoros P.
    Sachanas, Sotirios P.
    Kontopidou, Flora
    Yiakoumis, Xanthi
    Kokoris, Styliani
    Dimitriadou, Evangelia
    Dimopoulou, Maria
    Moschogiannis, Maria
    Korkolopoulou, Penelope
    Kyrtsonis, Marie-Christine
    Siakantaris, Marina
    Papadaki, Helen A.
    Angelopoulou, Maria K.
    BLOOD, 2011, 118 (21) : 1167 - 1167
  • [6] Rituximab monotherapy is the treatment of choice of splenic marginal zone lymphoma (SMZL)
    Kalpadakis, C.
    Pangalis, G. A.
    Vassilakopoulos, T. P.
    Dimopoulou, M. N.
    Kyrtsonis, M.
    Korkolopoulou, P.
    Kontopidou, F.
    Siakantaris, M.
    Dimitriadou, E.
    Panayiotidis, P.
    Papadaki, H.
    Angelopoulou, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 191 - 191
  • [7] TREATMENT OF SPLENIC MARGINAL ZONE LYMPHOMA
    Julhakyan, H.
    Grjimolovskiy, A.
    Karagulyan, S.
    Magomedova, A.
    Kremenetskaya, A.
    Kravchenko, S.
    Obukhova, T.
    Kaplanskaya, I.
    Samoylova, R.
    Vorobjev, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 622 - 622
  • [8] Treatment of splenic marginal zone lymphoma
    Kalpadakis, Christina
    Pangalis, Gerassimos A.
    Angelopoulou, Maria K.
    Vassilakopoulos, Theodoros P.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2017, 30 (1-2) : 139 - 148
  • [9] Splenic marginal zone lymphoma. Searching for diagnostic and prognostic markers
    Mollejo, M
    Camacho, FI
    Sanchez-Verde, L
    Ruiz-Ballesteros, E
    Algara, P
    Menarguez, J
    Cruz, MA
    Piris, MA
    LABORATORY INVESTIGATION, 2006, 86 : 237A - 237A
  • [10] Splenic marginal zone lymphoma. Searching for diagnostic and prognostic markers
    Mollejo, M
    Camacho, FI
    Sanchez-Verde, L
    Ruiz-Ballesteros, E
    Algara, P
    Menarguez, J
    Cruz, MA
    Piris, MA
    MODERN PATHOLOGY, 2006, 19 : 237A - 237A
12345